Physician

Mamoon M Elbedawi, MD

According to 2025 Medicare claims, Mamoon Elbedawi, MD (NPI: 1770662553) practices gastroenterology in the Flint, MI market, with the plurality of this provider's patient population coming from Genesee, MI. This provider's primary affiliated billing organization is MID MICHIGAN GASTROENTEROLOGY ASSOCIATES (NPI: 1003244120; TIN: 463557542) and primary practice location at 48503-5902. Elbedawi is affiliated with the POM ACO (ACO ID: A1297), participating under the MSSP model.

Elbedawi's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,059 traditional Medicare patients, billed 4,333 HCPCS/CPT codes, and received $369,790 in Medicare payments. The top billing code was 45378 (Diagnostic exam of large bowel using a flexible endoscope). Part D data shows 1,174 prescription claims across 771 beneficiaries totaling $292,090 in drug costs, led by Humira(Cf) Pen (Adalimumab). Open Payments data shows 60 records totaling $1,562. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $179,874 to $369,790. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $43,187 and ending at $292,090. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	569	1,444	$179,874
2016	727	1,809	$201,772
2017	628	1,408	$161,975
2018	778	1,691	$207,744
2019	861	2,100	$247,799
2020	698	1,820	$200,667
2021	696	2,473	$227,432
2022	806	3,419	$292,425
2023	1,001	4,036	$372,705
2024	1,059	4,333	$369,790

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	195	330	$43,187
2016	226	429	$74,315
2017	149	283	$12,847
2018	414	818	$508,950
2019	562	1,436	$606,003
2020	512	1,214	$498,027
2021	679	1,514	$306,891
2022	529	1,356	$428,081
2023	610	1,242	$633,223
2024	771	1,174	$292,090

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
45378	Diagnostic exam of large bowel using a flexible endoscope	102	107	$128
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	636	772	$98
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	157	193	$89
43239	Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope	388	432	$78
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	549	1,812	$60

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Humira(Cf) Pen	Adalimumab	26	728	$176,801
Creon	Lipase/Protease/Amylase	23	595	$23,550
Gavilyte-G	Peg3350/Sod Sulf,bicarb,cl/Kcl	312	364	$5,618
Peg-3350 And Electrolytes	Peg3350/Sod Sulf,bicarb,cl/Kcl	229	291	$3,918
Peg 3350-Electrolyte	Sodium Chloride/Nahco3/Kcl/Peg	61	65	$1,538

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	60	$1,562	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Mamoon M. Elbedawi, MD?

Tedicare shows public-source Medicare data for Mamoon M. Elbedawi, MD (NPI 1770662553), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mamoon M. Elbedawi, MD have ACO affiliation data?

Mamoon M. Elbedawi, MD is shown with ACO affiliation data for POM ACO (MSSP, ACO ID A1297).

What billing organization is linked to Mamoon M. Elbedawi, MD?

Mamoon M. Elbedawi, MD is linked to MID MICHIGAN GASTROENTEROLOGY ASSOCIATES (billing NPI 1003244120) in the available physician profile data.

Does Mamoon M. Elbedawi, MD have Open Payments data?

Mamoon M. Elbedawi, MD has 60 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.